Skip to main content

The Drug Discovery Initiative has developed relationships with several antibody development companies using humanized mouse and phage display platforms. UNC researchers can work with these companies under a fee-for-service arrangement or potentially through no-cost access in exchange for shared IP.

To submit targets for consideration and assessment, please use the AdvanTx Portal.